Document b5834BaNaMJn1qV9O86VooxQo

No Subject Document date Register number SENDER RECIPIENT Release? YES/Partial/ Reason/Exception (*) (if no/partial release) NO/Public 1 Meeting request on EFSA's scientific opinion on PFOS and PFOA 2 Meeting request on EFSA's scientific opinion on PFOS and PFOA 2 Annex 1 Final 3M Comments 17 January 2019 Ares(2019)792881 3M 6 February 2019 Ares(2019)795154 European Commission 20 August 2018 Ares(2019)868274 3M European Commission 3M Partial Partial Partial Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Documents in Annex to document 2 - publicly available articles from scientific journals of which the Commission received a copy Butenhoff, J. L., 2012, `Distribution of perfluorooctanesulfonate and perfluorooctanoate into human plasma lipoprotein fractions', Toxicology Letters 210 (2012) 360- 365, 2 Annex 2 doi:10.1016/j.toxlet.2012.02.013 2 Annex 3 2 Annex 4 2 Annex 5 2 Annex 6 2 Annex 7 2 Annex 8 Chang J. L., 2012, `Increasing dietary saturated fat is negatively associated with plasma concentrations of non-high-density lipoprotein cholesterol and perfluorooctanoate (PFOA) in APOE*3-Leiden. Cetp mice at constanct low-level dietary PFOA' Chang J. L., 2017 `Evaluation of Serum Lipid, Thyroid, and Hepatic Clinical Chemistries in Association With Serum Perfluorooctanesulfonate (PFOS) in Cynomolgus Monkeys After Oral Dosing With Potassium PFOS Toxixol Sci' Toxicological Sciences, 156(2), 2017, 387-401. Convertino J. L., 2018 `Stochastic PharmacokineticPharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA)' Toxicology Sciences, 163(1), 2018, 293-306. Ngueta J. L., 2017 `Quantitative bias analysis of a reported association between perfluoroalkyl substances (PFAS) and endometriosis: The influence of oral contraceptive use' Environment International 104 (2017) 118-121. Olsen J. L., 2017 Per- and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood donors, 2000-2015' Environmental Research 157 2017 87-95 Ruark J. L., 2017 `Quantitative bias analysis for epidemiological associations of perfluoroalkyl substance serum concentrations and early onset of menopause' Environment International 99 (2017) 245-254 Verner J. L., 2015 Associations of Perfluoroalkyl Substances (PFAS) with Lower Birth Weight: An Evaluation of Potential Confounding by Glomerular Filtration Rate Using a Physiologically Based Pharmacokinetic Model (PBPK) Environmental Health 2 Annex 9 Perspectives 123 number 12 (December 2015). Wu J.L., 2015 `Can the observed association between serum perfluoroalkyl substances and delayed menarche be explained on the basis of puberty-related changes in physiology and 2 Annex 10 pharmacokinetics?' Environment International 82 (2015) 61-68. 3 Meeting request on EFSA's scientific opinion on PFOS and PFOA 16 January 2019 4 A Brief Synopsis of 3M Legacy PFAS Health Science Research 18 January 2019 5 Meeting request on EFSA's scientific opinion on PFOS and PFOA 22 January 2019 Comments on the European Food Safety Authority (EFSA) lowering 10 November 6 tolerable weekly intake (TWI) for certain PFAS substances 2020 7 3M letter to EC DG SANTE - EFSA opinion - 10 November 13 November 2020 8 3M Letter to EC DG Sante - EFSA opinion 17 December 2020 Comments on the European Food Safety Authority (EFSA) lowering 23 December 9 tolerable weekly intake (TWI) for certain PF AS substances 2020 Ares(2019)868274 Ares(2019)868274 Ares(2019)868274 Ares(2019)868274 Ares(2019)868274 Ares(2019)868274 Ares(2019)868274 Ares(2019)868274 Ares(2019)868274 Ares(2019)800587 3M Ares(2019)868274 3M Ares(2019)868274 3M Ares(2020)7877483 3M Ares(2020)7877483 3M Ares(2020)7877483 BCW (consultant to 3M) Ares(2020)7893044 European Commission European Commission European Commission European Commission European Commission European Commission European Commission 3M Article 4(2) of Regulation (EC) No 1049/2001 No Partial Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(2) of Regulation (EC) No 1049/2001 No Article 4(2) of Regulation (EC) No 1049/2001 No Article 4(2) of Regulation (EC) No 1049/2001 No Article 4(2) of Regulation (EC) No 1049/2001 No Article 4(2) of Regulation (EC) No 1049/2001 No Article 4(2) of Regulation (EC) No 1049/2001 No No Partial Partial Partial Partial Partial Partial Partial Article 4(2) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001; out of scope Article 4(1)(b) of Regulation (EC) No 1049/2001; out of scope Article 4(1)(b) of Regulation (EC) No 1049/2001 Ref. Ares(2021)6388436 - 19/10/2021 Comments on the European Food Safety Authority (EFSA) lowering 10 weekly intake (TWI) for certain PF AS substances 1 February 2021 Ares(2021)852851 3M European Commission Information on questions in Belgium & proposed discussions on 11 future standards 14 July 2021 Ares(2021)4608511 3M European Commission Food Drink Europe General comments on the current drafts under discussion regarding perflourinated substances (PFAS) in food 11 August 2021 Ares(2021)5061800 Food Drink Europe European Commission 12 (Annex) Food Drink Europe General comments on the current drafts under 30 July 2021 13 discussion regarding perflourinated substances (PFAS) in food AIPCE CEP position on proposal of EC related to PFAS in fish, 14 crusteceans and molluscs (Annex) 29 July 2021 Ares(2021)5061800 Food Drink Europe European Commission Ares(2021)5062194 AIPCE - CEP European Commission 15 Revisiting Regulation 1881/2006 on MLs of PAFS 29 July 2021 Ares(2021)5062914 AIPCE - CEP European Commission FoodDrinkEurope comments on the current drafts under discussion 11 August 2021 Ares(2021)5244440 European 16 regarding perflourinated substances (PFAS) in food Commission Revisiting Regulation 1881/2006 on Mls of PAFS -AIPCE CEP 17 position 11 August 2021 Ares(2021)5244707 European Commission Food Drink Europe AIPCE - CEP 18 BEUC comments to the Food Contact Materials REFIT evaluation 14 May 2019 BEUC comments to the Food Contact Materials REFIT evaluation- 18a attachment Meeting with BEUC re. new evidence on fluorinated substances in 19 food packaging 24 May 2017 Meeting with BEUC re. new evidence on fluorinated substances in 19a food packaging- attachment Ares(2021)5490019 BEUC Ares(2021)5490019 BEUC Ares(2021)5492280 BEUC Ares(2021)5492280 BEUC European Commission European Commission European Commission European Commission 20 EU situation regarding fluorination of FCM plastics 9 July 2021 Ares(2021)5492219 CHEM Trust European Commission 21 Meeting request from Plastics Europe 11 July 2020 Ares(2021)5491381 Plastics Europe European Commission Civil society findings of widespread presence of harmful chemicals 2 June 2021 22 PFAS widespread in food packaging + meeting request Ares(2021)3629387 HEAL, Arnika, CHEM, IPEEN European Commission Civil society findings of widespread presence of harmful chemicals 22a PFAS widespread in food packaging + meeting request- attachment Ares(2021)3629387 23 Letter from DE citizen to Cssr on toxic substances in the environment 23 March 2021 Ares(2021)2045036 DE Citizen Single-use tableware made of popular plastic alternatives may contain 24 harmful chemicals, new consumer test shows 27 May 2021 Ares(2021)3512199 BEUC European Commission European Commission 25 Letter from PO Citizen on PFAs in food packaging 13 May 2021 Ares(2021)3259209 PO Citizen European Commission 26 E-mail from EU to PO Citizen 20 May 2021 Ares(2021)3375433 European Commission PO Citizen Letter to Cssr on Chemical Strategy for Sustainability concerning 27 protection the health of EU citizens 9 September 2020 Ares(2020)4791603 European Commission ChemSec Endocrine Society welcomes Chemicals Strategy measures to control The Endocrine 28 EDCs 15 October 2020 Ares(2020)5640644 Society European Commission Health and Environment Alliance (HEAL) - Important elements to consider for health protection and disease prevention in the forthcoming discussions about the Chemicals Strategy for 10 September 2020 Ares(2020)4757707 HEAL European Commission 29 Sustainability Letter to Comissioner concerning Chemicals Strategy, Beating 30 Cancer Plan, and Endocrine Disruptor 23 October 2020 Ares(2020)6053696 The Endocrine Society European Commission Letter to Comissioner concerning Chemicals Strategy, Beating 30a Cancer Plan, and Endocrine Disruptor- attachment Ares(2020)6053696 31 Meeting request from BCW 15 March 2021 Ares(2021)5834575 BCW (consultant to European Commission 3M) Partial Partial Yes Partial Partial Partial Partial Partial Partial Partial Partial Partial Partial Partial Partial Partial Partial Partial Partial Partial Partial Partial Partial Article 4(1)(b) of Regulation (EC) No 1049/2001, out of scope Article 4(1)(b) of Regulation (EC) No 1049/2001 Full access Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001; out of scope Partial Partial Partial Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001 Article 4(1)(b) of Regulation (EC) No 1049/2001